Smithfield Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Buy |
92,186
+276
| +0.3% | +$31.9K | 0.48% | 42 |
|
|
2025
Q4 | $9.66M | Buy |
91,910
+1,598
| +2% | +$150K | 0.43% | 44 |
|
|
2025
Q3 | $7.57M | Sell |
90,312
-1,231
| -1% | -$101K | 0.34% | 51 |
|
|
2025
Q2 | $7.23M | Sell |
91,543
-873
| -0.9% | -$69.4K | 0.34% | 50 |
|
|
2025
Q1 | $8.29M | Buy |
92,416
+1,430
| +2% | +$134K | 0.42% | 45 |
|
|
2024
Q4 | $9.04M | Sell |
90,986
-25,791
| -22% | -$2.66M | 0.45% | 42 |
|
|
2024
Q3 | $13.2M | Buy |
116,777
+298
| +0.3% | +$35.4K | 0.65% | 32 |
|
|
2024
Q2 | $14.4M | Sell |
116,479
-1,575
| -1% | -$203K | 0.76% | 28 |
|
|
2024
Q1 | $15.6M | Sell |
118,054
-4,331
| -4% | -$534K | 0.83% | 28 |
|
|
2023
Q4 | $13.3M | Sell |
122,385
-470
| -0.4% | -$48.8K | 0.75% | 31 |
|
|
2023
Q3 | $12.6M | Buy |
122,855
+91,040
| +286% | +$9.81M | 0.78% | 29 |
|
|
2023
Q2 | $3.67M | Sell |
31,815
-198
| -0.6% | -$22.5K | 0.22% | 65 |
|
|
2023
Q1 | $3.4M | Buy |
32,013
+661
| +2% | +$71.4K | 0.22% | 63 |
|
|
2022
Q4 | $3.48M | Buy |
31,352
+758
| +2% | +$77.5K | 0.23% | 66 |
|
|
2022
Q3 | $2.63M | Buy |
30,594
+1,050
| +4% | +$93.7K | 0.19% | 72 |
|
|
2022
Q2 | $2.69M | Buy |
29,544
+264
| +0.9% | +$23.4K | 0.19% | 73 |
|
|
2022
Q1 | $2.4M | Sell |
29,280
-254
| -0.9% | -$20K | 0.15% | 81 |
|
|
2021
Q4 | $2.27M | Sell |
29,534
-295
| -1% | -$23.5K | 0.14% | 88 |
|
|
2021
Q3 | $2.25M | Sell |
29,829
-500
| -2% | -$38K | 0.15% | 84 |
|
|
2021
Q2 | $2.36M | Sell |
30,329
-1,456
| -5% | -$108K | 0.16% | 81 |
|
|
2021
Q1 | $2.34M | Sell |
31,785
-4,101
| -11% | -$303K | 0.16% | 80 |
|
|
2020
Q4 | $2.8M | Sell |
35,886
-1,061
| -3% | -$81.1K | 0.2% | 70 |
|
|
2020
Q3 | $2.92M | Buy |
36,947
+1,878
| +5% | +$147K | 0.24% | 66 |
|
|
2020
Q2 | $2.59M | Buy |
35,069
+578
| +2% | +$43.5K | 0.23% | 65 |
|
|
2020
Q1 | $2.53M | Buy |
34,491
+633
| +2% | +$49.7K | 0.27% | 56 |
|
|
2019
Q4 | $2.94M | Buy |
33,858
+73
| +0.2% | +$6K | 0.27% | 60 |
|
|
2019
Q3 | $2.71M | Buy |
33,785
+531
| +2% | +$42.6K | 0.27% | 60 |
|
|
2019
Q2 | $2.66M | Buy |
33,254
+320
| +1% | +$24.5K | 0.28% | 57 |
|
|
2019
Q1 | $2.61M | Buy |
32,934
+1,395
| +4% | +$104K | 0.28% | 54 |
|
|
2018
Q4 | $2.3M | Sell |
31,539
-1,959
| -6% | -$138K | 0.27% | 55 |
|
|
2018
Q3 | $2.27M | Sell |
33,498
-421
| -1% | -$26.8K | 0.25% | 59 |
|
|
2018
Q2 | $1.97M | Buy |
33,919
+6,362
| +23% | +$359K | 0.23% | 60 |
|
|
2018
Q1 | $1.43M | Sell |
27,557
-981
| -3% | -$53K | 0.17% | 81 |
|
|
2017
Q4 | $1.53M | Buy |
28,538
+3,065
| +12% | +$170K | 0.19% | 78 |
|
|
2017
Q3 | $1.56M | Sell |
25,473
-262
| -1% | -$15.9K | 0.21% | 69 |
|
|
2017
Q2 | $1.57M | Buy |
25,735
+281
| +1% | +$17.1K | 0.23% | 62 |
|
|
2017
Q1 | $1.54M | Sell |
25,454
-59
| -0.2% | -$3.58K | 0.24% | 62 |
|
|
2016
Q4 | $1.43M | Buy |
25,513
+2,094
| +9% | +$123K | 0.24% | 62 |
|
|
2016
Q3 | $1.4M | Buy |
23,419
+628
| +3% | +$36.7K | 0.25% | 59 |
|
|
2016
Q2 | $1.25M | Hold |
22,791
| – | – | 0.24% | 63 |
|
|
2016
Q1 | $1.15M | Sell |
22,791
-75
| -0.3% | -$3.67K | 0.22% | 64 |
|
|
2015
Q4 | $1.15M | Buy |
22,866
+35
| +0.2% | +$1.76K | 0.24% | 62 |
|
|
2015
Q3 | $1.07M | Buy |
22,831
+734
| +3% | +$39K | 0.23% | 66 |
|
|
2015
Q2 | $1.2M | Buy |
22,097
+639
| +3% | +$35.8K | 0.24% | 62 |
|
|
2015
Q1 | $1.18M | Sell |
21,458
-1,236
| -5% | -$70K | 0.23% | 65 |
|
|
2014
Q4 | $1.23M | Sell |
22,694
-371
| -2% | -$20.7K | 0.25% | 61 |
|
|
2014
Q3 | $1.3M | Buy |
23,065
+1,170
| +5% | +$65.7K | 0.26% | 64 |
|
|
2014
Q2 | $1.21M | Buy |
21,895
+4,289
| +24% | +$234K | 0.24% | 68 |
|
|
2014
Q1 | $954K | Buy |
17,606
+159
| +0.9% | +$8.23K | 0.19% | 97 |
|
|
2013
Q4 | $834K | Buy |
17,447
+218
| +1% | +$9.96K | 0.17% | 107 |
|
|
2013
Q3 | $783K | Hold |
17,229
| – | – | 0.18% | 104 |
|
|
2013
Q2 | $763K | Buy |
+17,229
| New | +$770K | 0.18% | 103 |
|
Other funds holding MRK
VCM
VPM
Smithfield Trust's MRK Position: Q1 2026 in Review
Smithfield Trust increased its Merck (MRK) stake by 0.3% in Q1 2026, buying an estimated $31.9K and bringing the position to 92,186 shares worth $11.1M. The position accounts for 0.48% of the portfolio, ranked #42.
Smithfield Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.6M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Smithfield Trust held 92,186 shares of Merck worth $11.1M as of Q1 2026.
- Smithfield Trust bought 276 Merck shares in Q1 2026, an estimated $31.9K.
- Merck made up 0.48% of Smithfield Trust's portfolio in Q1 2026, its #42 holding.
- Smithfield Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Smithfield Trust's Merck position peaked at $15.6M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.